Champion Investments, Inc.
OOTC:CHAM0.00
USD
+0.00
(+100.00%)
ISIN
US1585301054
CUSIP
158530105
Return %
Stock
S&P 500
1Y
100.00
14.20
3Y
-99.86
81.12
5Y
-99.80
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Kerri G. Schomette
- Full Time Employees
- 3
- Sector
- Finance
- Industry
- Financial conglomerates
- Address
- 5850 San Felipe Rowlett TX United States 77057
- IPO Date
- Nov 9, 2007
- Website
- championinvestments.com
- Similar Companies
- Business
- Champion Investments, Inc. (CHAM:OTCPK) operates as a publicly traded investment firm pursuing regulation as a Business Development Company, focusing on equity and venture capital investments in early-stage, emerging, small- to middle-market companies, micro-investments, high-growth opportunities, acquisitions, buyouts, and recapitalizations in the United States; it targets the technology, life sciences, medical, and consumer sectors, with preferences for companies generating revenues up to $1 million in emerging stages, $2 million to $25 million with 10%-30% EBITDA in recapitalizations, and under $25 million in high-growth phases, aiming for returns over three-to-seven-year horizons. The firm, founded in 2009 and headquartered in Houston, Texas, partners with entrepreneurial executives to execute proprietary strategies in underserved high-impact categories. It maintains operations through a leadership team including Chairman and CEO Dr. Kerri G. Schomette, CFO and Chief Compliance Officer Desmonde C. A. Cowdery, and Vice President of Investor Relations Adam Parsons. Recent investments include equity stakes in Dakota Life Sciences, an anti-infective pharmaceutical company; Active Faith, Inc., a Christian sports apparel brand; and Thru Pharma, LLC, an innovative pharmaceutical organization, alongside appointments of Desmonde C. A. Cowdery as CFO and Chief Compliance Officer and Robert Hill as an independent director.